Nirsevimab Library
This is a collection of current resources related to Nirsevimab.
RSV Prevention in Infants: Promising Products, But at What Cost?
This commentary is related to two studies on the cost-effectiveness of maternal vaccination and nirsevimab for infants for the prevention of respiratory syncytial virus (RSV). …
Ask aRCie
Respiratory Diseases Surge While Immunizations Wane
2025
· Children's Hospital Colorado
The newsletter article highlights a rise in respiratory diseases like RSV, COVID-19, and influenza in Colorado due to low vaccination rates. It describes how children …
Efficacy of Nirsevimab Against Respiratory Syncytial Virus Lower Respiratory Tract Infections in Preterm and Term Infants, and Pharmacokinetic Extrapolation to Infants With Congenital Heart Disease and Chronic Lung Disease: A Pooled Analysis of Randomised Controlled Trials
2023
· Children's Hospital Colorado,
· University of the Witwatersrand,
· Northwestern University,
· Dr. Georgi Stranski University Hospital,
· Quironsalud Madrid University Hospital,
· State University of New York - Upstate Medical University
This article describes a study on the effectiveness of nirsevimab in preventing respiratory syncytial virus (RSV) infections in infants. It focuses on both preterm and …
The Burden of Respiratory Syncytial Virus Lower Respiratory Tract Disease in Infants in the United States: A Synthesis
This article discusses the significant burden of respiratory syncytial virus (RSV) in infants in the United States. It covers the epidemiology, hospitalization rates, mortality, costs, …
An Evaluation of 2015-2019 United States Respiratory Syncytial Virus Hospitalizations as a Framework to Develop Potential Strategies for the Prevention of the Hospital Burden Among Infants
This article evaluates RSV hospitalizations in the U.S. from 2015 to 2019 to develop strategies for reducing hospital burdens among infants. It describes two prevention …